According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Lung cancer in never-smokers is also occurring almost exclusively as adenocarcinoma, which has become the most dominant of ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

Air pollution is the leading cause behind the rise in lung cancer cases among non-smokers, especially women and those living ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...